ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs backed by Columbus Venture Partners, has announced that the ...
Read moreCocoon Bioscience ha levantado €2 millones en una ronda de inversión liderada por MONDRAGON, Bexen Medical, Columbus Venture Partners y Cleon Capital, y que ha incluido a su vez a Viscofan, la esta...
Read more Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Vivet Therapeutics (“Vivet”) announced today an agreement whereby Mirum has the exclusive option to develop and subsequently commercialize Viv...
Read moreAlmirall, a global biopharmaceutical company based in Barcelona, and Tyris Therapeutics, a next generation gene therapy company founded by Columbus Venture Partners, have announced a strategic ...
Read moreLa compañía biotecnológica Algenex ha cerrado una ronda de financiación privada por valor de 7,4 millones de euros liderada por MasterLux, inversor asesorado por Cleon Capital y Vita Advisory. Est...
Read moreAura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that it closed a $40 million Series D financing. New investor Medicxi led the round, with
Read moreVivet Therapeutics (‘Vivet’), an emerging biotechnology company developing novel gene therapies for rare, inherited metabolic diseases, announced it has raised €37.5 million in a Series A financ...
Read more